期刊
JOURNAL OF HETEROCYCLIC CHEMISTRY
卷 58, 期 11, 页码 2090-2101出版社
WILEY
DOI: 10.1002/jhet.4332
关键词
anti-cancer activity; forskolin; indole; tsriazole
资金
- UGC, New Delhi
A novel series of hybrid molecules combining forskolin, indole, and 1,2,3-triazoles were synthesized and evaluated for potential anticancer activity. Compound 5g showed the highest potency across various cell lines. In silico studies indicated that the synthesized compounds exhibited stronger binding affinity compared to forskolin.
Biologically important three different pharmacophores, forskolin, indole and 1,2,3-triazoles are coupled to obtain a hybrid molecule. Here, we described the synthesis of novel series of forskolin-indole-triazole conjugates 5a-5l by using the Cu(I) catalyzed 1,3-dipolar cycloaddition reaction. Furthermore, the biological significance of the synthesized molecules was assessed by in silico and in vitro modes. All the synthesized compounds were evaluated for in vitro anticancer activity against PC-3, MCF-7, MDA-MB-231, COLO-205, HeLa, WRL-68, RAJI, CHANG and RAW-264.7 cell lines. Compound 5g was found to be the most potent in all the tested cell lines (IC50 range 9.6-21.66 mu g/ml, except COLO-205), 5a, 5b and 5k were observed to exert its effect only against WRL-68 (IC50 range 27.69-48.18 mu g/ml), when compared to parent 3 (IC50 > 100 mu g/ml, tested concentrations 10-50 mu g/ml) and standard Doxorubicin (IC50 range 0.42-3.16 mu g/ml). The most potent compound 5g (MEF50 0.57) was found non-toxic to human erythrocytes as compared to control (MEF50 0.60) at tested concentration (50 mu g/ml). In silico-based succinate dehydrogenase inhibition showed that the synthesized compounds were having potent binding affinity compared to forskolin. Predictive ADMET and toxicity risk assessment analysis revealed that most of the compounds were complying with the standard limit of Lipinski's rule of five for oral bioavailability.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据